Xenetic Biosciences (XBIO)
NASDAQ:XBIO
Holding XBIO?
Track your performance easily

Xenetic Biosciences (XBIO) Financial Statements

289 Followers

Xenetic Biosciences Financial Overview

Xenetic Biosciences's market cap is currently ―. The company's EPS TTM is $-2.915; its P/E ratio is -1.40; Xenetic Biosciences is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 510.82K$ 611.20K$ 651.00K$ 605.84K$ 486.97K
Gross Profit$ 510.82K$ 611.17K$ 651.00K$ 605.84K$ 2.88M
Ebit$ -1.20M$ -1.06M$ -1.05M$ -910.65K$ -3.54M
Ebitda$ -1.20M$ -1.06M-$ -910.65K$ -3.54M
Net Income Common Stockholders$ -1.20M$ -1.06M$ -1.05M$ -856.55K$ -1.48M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 7.82M$ 9.78M$ 10.73M$ 11.99M$ 13.10M
Total Assets$ 9.39M$ 11.96M$ 12.75M$ 13.72M$ 14.72M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -7.82M$ -9.78M$ -10.73M$ -11.99M$ -13.10M
Total Liabilities$ 716.49K$ 1.07M$ 871.32K$ 856.37K$ 1.07M
Stockholders Equity$ 8.68M$ 10.89M$ 11.88M$ 12.86M$ 13.65M
Cash Flow-
Free Cash Flow$ -1.16M$ -949.63K-$ -1.10M$ -750.91K
Operating Cash Flow$ -1.16M$ -949.63K$ -1.27M$ -1.10M$ -750.91K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Xenetic Biosciences Earnings and Revenue History

Xenetic Biosciences Debt to Assets

Xenetic Biosciences Cash Flow

Xenetic Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis